NASDAQ:DRIO DarioHealth (DRIO) Stock Price, News & Analysis $8.20 -0.15 (-1.80%) Closing price 03:56 PM EasternExtended Trading$8.14 -0.06 (-0.73%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About DarioHealth Stock (NASDAQ:DRIO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get DarioHealth alerts:Sign Up Key Stats Today's Range$8.20▼$8.3050-Day Range$6.37▼$9.5652-Week Range$5.93▼$17.74Volume4,739 shsAverage Volume7,596 shsMarket Capitalization$59.94 millionP/E RatioN/ADividend YieldN/APrice Target$10.50Consensus RatingHold Company Overview DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes. The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education. Users engage with the mobile application to log measurements, access nutrition and exercise recommendations, and connect with certified health coaches. Employers, health plans, pharmacies and government agencies can license the platform on a subscription basis, enabling large-scale deployment of virtual care programs and population health initiatives. Headquartered in New York, DarioHealth serves clients across the United States and selected international markets, leveraging partnerships with payors, pharmacy benefit managers and retailer pharmacies. The company’s go-to-market strategy focuses on embedding the Dario solution within existing care pathways, enabling care providers to remotely monitor patient progress, adjust treatment plans and drive adherence. DarioHealth went public on the NASDAQ under the ticker DRIO in mid-2021 following a business combination with a special purpose acquisition company. Under the leadership of CEO Elad Haramati, PhD, the company continues to expand its digital care offering, pursue new reimbursement pathways and advance its platform through ongoing product development.AI Generated. May Contain Errors. Read More DarioHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks59th Percentile Overall ScoreDRIO MarketRank™: DarioHealth scored higher than 59% of companies evaluated by MarketBeat, and ranked 388th out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingDarioHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialDarioHealth has a consensus price target of $10.50, representing about 28.0% upside from its current price of $8.20.Amount of Analyst CoverageDarioHealth has only been the subject of 2 research reports in the past 90 days.Read more about DarioHealth's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for DarioHealth are expected to grow in the coming year, from ($3.92) to ($2.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DarioHealth is -0.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DarioHealth is -0.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDarioHealth has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.95% of the float of DarioHealth has been sold short.Short Interest Ratio / Days to CoverDarioHealth has a short interest ratio ("days to cover") of 5.13.Change versus previous monthShort interest in DarioHealth has recently decreased by 3.19%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDarioHealth does not currently pay a dividend.Dividend GrowthDarioHealth does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.68 News SentimentDarioHealth has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for DarioHealth this week, compared to 2 articles on an average week. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DarioHealth insiders have not sold or bought any company stock.Percentage Held by Insiders3.50% of the stock of DarioHealth is held by insiders.Percentage Held by Institutions33.39% of the stock of DarioHealth is held by institutions.Read more about DarioHealth's insider trading history. Receive DRIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DRIO Stock News HeadlinesDarioHealth (DRIO) Q1 2026 Earnings TranscriptMay 14, 2026 | finance.yahoo.comDarioHealth Corp (DRIO) Q1 2026 Earnings Call Highlights: Navigating Growth and Strategic ...May 14, 2026 | uk.finance.yahoo.comYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.May 19 at 1:00 AM | Profits Run (Ad)DarioHealth Reports Q1 2026 Results: Full Earnings Call TranscriptMay 13, 2026 | uk.finance.yahoo.comDarioHealth Corp. (DRIO) Q1 2026 Earnings Call TranscriptMay 13, 2026 | seekingalpha.comDarioHealth Reports First Quarter 2026 Financial and Operating ResultsMay 13, 2026 | prnewswire.comDarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026May 4, 2026 | prnewswire.comDario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative ResearchApril 20, 2026 | prnewswire.comSee More Headlines DRIO Stock Analysis - Frequently Asked Questions How have DRIO shares performed this year? DarioHealth's stock was trading at $11.38 at the beginning of 2026. Since then, DRIO stock has decreased by 27.9% and is now trading at $8.20. How were DarioHealth's earnings last quarter? DarioHealth Corp. (NASDAQ:DRIO) announced its quarterly earnings data on Wednesday, May, 14th. The company reported ($2.80) EPS for the quarter, missing analysts' consensus estimates of ($1.40) by $1.40. The firm earned $6.75 million during the quarter, compared to analysts' expectations of $7.48 million. DarioHealth had a negative net margin of 192.23% and a negative trailing twelve-month return on equity of 60.52%. Read the conference call transcript. When did DarioHealth's stock split? Shares of DarioHealth reverse split before market open on Thursday, August 28th 2025.The 1-20 reverse split was announced on Monday, August 25th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Does DarioHealth have any subsidiaries? DarioHealth subsidiaries include these companies: PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc.. How do I buy shares of DarioHealth? Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DarioHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA). Company Calendar Last Earnings5/14/2025Today5/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 DRIO's financial health is in the Yellow zone, according to TradeSmith. DRIO has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:DRIO CIK1533998 Webwww.mydario.com Phone(833) 914-3796Fax972-4770-4059Employees200Year Founded2011Price Target and Rating Average Price Target for DarioHealth$10.50 High Price Target$11.00 Low Price Target$10.00 Potential Upside/Downside+28.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($8.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$41.71 million Net Margins-192.23% Pretax Margin-191.57% Return on Equity-60.52% Return on Assets-37.08% Debt Debt-to-Equity Ratio0.50 Current Ratio3.07 Quick Ratio2.62 Sales & Book Value Annual Sales$22.36 million Price / Sales2.68 Cash FlowN/A Price / Cash FlowN/A Book Value$8.53 per share Price / Book0.96Miscellaneous Outstanding Shares7,310,000Free Float7,056,000Market Cap$59.94 million OptionableNo Data Beta1.09 Social Links Don't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:DRIO) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
